On July 1, 2025, the Center for Medicare and Medicaid Innovation (CMMI) introduced the EOM, the pilot program that is the successor to the Oncology Care Model (OCM). The EOM is a 5-year voluntary model intended to transform care for cancer patients, reduce spending, and improve the quality of care.¹
Our panel gathered to share their perspectives on the EOM and some of the opportunities and challenges of the new model.
Key highlights
- Practices participating in the EOM likely believe they have the infrastructure and resources to be successful, based on their experience with the OCM
- According to CMS, 44 practices have chosen to participate in the EOM, compared with 122 practices for the OCM.² The panel felt that the downside risk may have been challenging for practices and kept participation lower vs the OCM
- New aspects of the EOM, including the social determinants of health screening, were favorably viewed as potentially improving the quality of care and reducing healthcare disparities
- Concerns were raised about the reduction in MEOS payments and how practices would be able to manage the additional workload required by the EOM and stay financially viable